Switzerland, Nov. 25 -- GlaxoSmithKline Biologicals (GSK), one of the world's largest healthcare companies, has taken a bold step toward its net-zero goals by partnering with ABB to upgrade legacy motors at its vaccine manufacturing facility in Tuas South, Singapore. Through this strategic move, GSK is projected to save up to 615 MWh of electricity annually, reduce CO? emissions by 246 tons, and lower energy costs by up to USD 130,000, exceeding the factory's decarbonization target by 25 percent. The initiative supports GSK's global ambition to reduce greenhouse gas emissions by 80 percent by 2030 and reinforces Singapore's role as a hub for sustainable pharmaceutical innovation.Delivered in two phases between September and December 20254 a...